Cargando…
Nanotechnology for Topical Drug Delivery to the Anterior Segment of the Eye
Topical drug delivery is one of the most challenging aspects of eye therapy. Eye drops are the most prevalent drug form, especially for widely distributed anterior segment eye diseases (cataracts, glaucoma, dry eye syndrome, inflammatory diseases, etc.), because they are convenient and easy to apply...
Autores principales: | Vaneev, Alexander, Tikhomirova, Victoria, Chesnokova, Natalia, Popova, Ekaterina, Beznos, Olga, Kost, Olga, Klyachko, Natalia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8621153/ https://www.ncbi.nlm.nih.gov/pubmed/34830247 http://dx.doi.org/10.3390/ijms222212368 |
Ejemplares similares
-
A Direct Comparison of Peptide Drug Delivery Systems Based on the Use of Hybrid Calcium Phosphate/Chitosan Nanoparticles versus Unmixed Calcium Phosphate or Chitosan Nanoparticles In Vitro and In Vivo
por: Popova, Ekaterina, et al.
Publicado: (2023) -
Chitosan-Covered Calcium Phosphate Particles Co-Loaded with Superoxide Dismutase 1 and ACE Inhibitor: Development, Characterization and Effect on Intraocular Pressure
por: Popova, Ekaterina, et al.
Publicado: (2023) -
Superoxide Dismutase 1 Nanoparticles (Nano-SOD1) as a Potential Drug for the Treatment of Inflammatory Eye Diseases
por: Vaneev, Alexander N., et al.
Publicado: (2021) -
Superoxide Dismutase 1 Nanozyme for Treatment of Eye Inflammation
por: Kost, Olga A., et al.
Publicado: (2016) -
Topical Drug Delivery to the Posterior Segment of the Eye
por: Löscher, Marina, et al.
Publicado: (2022)